Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:4) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 121 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 144 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 144 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 60.3 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 69.8 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 68.3 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 216 | pmol/sample |
| - | PE(36:4) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 220 | pmol/sample |
| - | PE(36:4) | C | 0.0 | BCD100322A01 | 112 | pmol/sample |
| - | PE(36:4) | C | 0.5 | BCD100322A03 | 152 | pmol/sample |
| - | PE(36:4) | C | 1.0 | BCD100322A07 | 174 | pmol/sample |
| - | PE(36:4) | C | 2.0 | BCD100322A11 | 215 | pmol/sample |
| - | PE(36:4) | C | 4.0 | BCD100322A15 | 64.1 | pmol/sample |
| - | PE(36:4) | C | 8.0 | BCD100322A19 | 73.7 | pmol/sample |
| - | PE(36:4) | C | 12.0 | BCD100322A23 | 89.7 | pmol/sample |
| - | PE(36:4) | C | 24.0 | BCD100322A27 | 266 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 158 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 206 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 161 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 64.4 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 77.2 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 213 | pmol/sample |
| - | PE(36:4) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 358 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 0.5 | BCD100322A04 | 151 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 1.0 | BCD100322A08 | 206 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 2.0 | BCD100322A12 | 104 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 4.0 | BCD100322A16 | 78.9 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 8.0 | BCD100322A20 | 78.1 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 12.0 | BCD100322A24 | 90.9 | pmol/sample |
| - | PE(36:4) | 25OH-Chol | 24.0 | BCD100322A28 | 413 | pmol/sample |